Thrombosis, or blood clot formation, can be life-threatening if ignored. Learn about its causes, early warning signs, and ...

Imaging findings of in situ pulmonary artery thrombosis associated with radiation therapy are different from acute pulmonary emboli and do not appear to embolize Leesburg, VA, October 9, ...

Hepatic artery thrombosis is a severe, early complication of orthotopic liver transplantation (OLT), with a reported mean incidence of 4–15% in adults; however, it remains unclear which patients are ...

Today, October 13, is World Thrombosis Day, a global healthcare event observed annually to raise awareness about thrombosis, ...

Hepatic artery thrombosis (HAT) is the most common vascular complication after liver transplantation, occurring in 2–5% of liver transplant recipients. As such, HAT is a major cause of morbidity and ...

Mesenteric ischemia remains a diagnostic challenge due to nonspecific symptoms, and delays in recognition lead to high ...

Last week at the New York Academy of Medicine four able investigators explained how coronary thrombosis, a common cause of heart failure, can be overcome and the victim’s life prolonged indefinitely.

Blood clots in the heart have various causes, such as an irregular heartbeat and damage to coronary artery walls. Blood clots can cause serious symptoms and may require immediate medical intervention.

The first evaluation for subclavian artery occlusive disease should always be a simple measurement of bilateral brachial artery blood pressures. A significant difference between the two extremities is ...

Thromboembolism occurs when a blood clot blocks a vein or artery, disrupting blood flow and potentially reaching vital organs ...

CEREBROVASCULAR insufficiency due to subclavian-artery occlusion is more frequent, more simply diagnosed and more easily treated than generally recognized. Only recently has attention been focused on ...

PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced outstanding 12-month data for the DynamX™ Coronary Bioadaptor System, the first ...